AstraZeneca PLC Ordinary Shares (AZN)

EBITDA

$20.69B

TTM · Period ending: · USD

AZN logo

AZN EBITDA

Latest reported$20.69B
AZN TTM EBITDA ($1.14B → $20.69B)
High-resolution chart · PNG

AZN ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AstraZeneca PLC Ordinary Shares EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
20,694,665,755
20,486,665,755
19,848,665,755
18,026,000,000
16,901,000,000
16,065,000,000
15,498,000,000
15,392,992,048
14,616,992,048
14,292,992,048
13,953,992,048
13,899,208,452
13,168,208,452
11,288,208,452
9,357,208,452
8,576,000,000
7,103,000,000
7,031,000,000
7,541,000,000
7,924,000,000
8,780,000,000
8,937,000,000
8,337,000,000
8,290,000,000
7,790,000,000
7,019,000,000
6,712,000,000
7,184,000,000
7,245,000,000
7,487,000,000
7,112,000,000
6,111,000,000
6,391,000,000
6,476,000,000
6,630,000,000
8,073,000,000
7,896,000,000
7,239,000,000
7,276,000,000
5,932,000,000
6,038,000,000
6,789,000,000
6,960,000,000
5,887,000,000
5,548,000,000
5,715,000,000
5,490,000,000
6,813,000,000
7,512,000,000
7,841,000,000
8,348,000,000
9,165,000,000
9,967,000,000
10,210,000,000
10,806,000,000
11,228,000,000
13,276,000,000
14,499,000,000
15,897,000,000
16,481,000,000
14,654,000,000
14,633,000,000
14,746,000,000
14,129,000,000
14,790,000,000
14,608,000,000
14,092,000,000
13,044,000,000
12,539,000,000
12,208,000,000
11,764,000,000
11,360,000,000
10,877,000,000
10,380,000,000
9,950,000,000
9,982,000,000
9,834,000,000
9,890,000,000
9,361,000,000
9,097,000,000
8,859,000,000
8,206,000,000
7,829,000,000
3,079,000,000
2,124,000,000
1,495,000,000
1,000,000,000
5,372,000,000
5,503,668,569
5,219,419,765
5,400,999,999
5,201,802,851
4,746,129,350
4,971,378,154
4,927,797,920
7,399,789,417
7,484,794,349
7,341,481,341
7,120,245,635
4,970,063,352
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.